Cerebellum’s Halliburton HAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$28K Sell
2,325
-354
-13% -$5.13K 0.13% 340
2020
Q2
$131K Buy
+2,679
New +$28.9K 0.09% 96
2019
Q3
Sell
-15,104
Closed -$343K 457
2019
Q2
$343K Buy
15,104
+3,533
+31% +$91.7K 0.28% 217
2019
Q1
$339K Buy
+11,571
New +$349K 0.29% 72
2018
Q4
Sell
-4,647
Closed -$188K 478
2018
Q3
$188K Buy
4,647
+921
+25% +$38.1K 0.3% 79
2018
Q2
$168K Sell
3,726
-401
-10% -$20K 0.28% 273
2018
Q1
$194K Buy
4,127
+1,448
+54% +$71.5K 0.25% 51
2017
Q4
$131K Buy
+2,679
New +$118K 0.09% 96

Other funds holding HAL

Cerebellum's HAL Position: Q3 2020 in Review

Cerebellum reduced its Halliburton (HAL) stake by 13% in Q3 2020, selling an estimated $5.13K and leaving 2,325 shares worth $28K. The position accounts for 0.13% of the portfolio, ranked #340.

Cerebellum first reported a position in HAL in Q4 2017 and has held it in 8 quarters since. The position peaked at $343K in Q2 2019. 679 funds tracked by Wall St. Rank hold HAL as of Q3 2020.

  • Cerebellum held 2,325 shares of Halliburton worth $28K as of Q3 2020.
  • Cerebellum sold 354 Halliburton shares in Q3 2020, an estimated $5.13K.
  • Halliburton made up 0.13% of Cerebellum's portfolio in Q3 2020, its #340 holding.
  • Cerebellum first reported a position in Halliburton in Q4 2017 and has held it in 8 quarters since.
  • Cerebellum's Halliburton position peaked at $343K in Q2 2019.
  • 679 funds tracked by Wall St. Rank held Halliburton as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.